Something Powerful

Tell The Reader More

The headline and subheader tells us what you're offering, and the form header closes the deal. Over here you can explain why your offer is so great it's worth filling out a form for.


  • Bullets are great
  • For spelling out benefits and
  • Turning visitors into leads.

Interview with HemoGenyx's Vladislav Sandler

In this video, Donald Leggatt, Head of Investor Relations at London South East, speaks with Vladislav Sandler, Co-Founder and Chief Executive Officer at HemoGenyx Pharmaceuticals

The biopharma company, which is listed on the London Stock Exchange, is developing novel therapies for the treatment of blood diseases. In this video interview, Sandler discusses a provisional patent application for the development of a new type of humanised mice, data that demonstrates that CDX antibodies can be used to attack and eliminate acute myelogenous leukaemia (AML) cells, as well as the next steps for HemoGenyx.

This video was filmed and produced by the well-known retail website www.lse.co.uk.

Louise Fordham
Written By

Add Your Response